These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2787406)

  • 21. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of natural killer cell activity by human seminal plasma in vitro: identification of 19-OH-PGE as the suppressor factor.
    Tarter TH; Cunningham-Rundles S; Koide SS
    J Immunol; 1986 Apr; 136(8):2862-7. PubMed ID: 3754269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.
    Montagna D; Maccario R; Ugazio AG; Mingrat G; Burgio GR
    Clin Exp Immunol; 1988 Jan; 71(1):177-81. PubMed ID: 2964956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.
    Rabinowich H; Herberman RB; Whiteside TL
    Cell Immunol; 1993 Dec; 152(2):481-98. PubMed ID: 7903063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB; Gutterman JU; Grimm EA
    Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes.
    Rabinowich H; Cohen R; Bruderman I; Steiner Z; Klajman A
    Cancer Res; 1987 Jan; 47(1):173-7. PubMed ID: 3491673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells.
    Bühling F; Kunz D; Reinhold D; Ulmer AJ; Ernst M; Flad HD; Ansorge S
    Nat Immun; 1994; 13(5):270-9. PubMed ID: 7833626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
    Blanchard DK; Kavanagh JJ; Sinkovics JG; Cavanagh D; Hewitt SM; Djeu JY
    Cancer Res; 1988 Nov; 48(22):6321-7. PubMed ID: 2972357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking of lymphokine activated killer (LAK) cell mediated cytotoxicity by cell-sized beads bearing tumor cell proteins.
    Chong AS; Hersh EM; Grimes WJ
    J Immunol; 1988 Dec; 141(12):4418-24. PubMed ID: 2848896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
    Espevik T; Figari IS; Ranges GE; Palladino MA
    J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
    Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
    Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity of natural killer cells: correlation with emperipolesis and surface enzymes.
    Burns ER; Zucker-Franklin D; Valentine F
    Lab Invest; 1982 Jul; 47(1):99-107. PubMed ID: 7045522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-2 activated killer cell activity is associated with the early phase of allograft rejection.
    Kamholz S; Roslin M; Mondragon M; Coons M; Tranbaugh R; Strashun A; Manjoney D; Norin A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):597-8. PubMed ID: 1990620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.